Vascular Biogenics Probability of Future Stock Price Finishing Over 0.2

VBLTDelisted Stock  USD 0.28  0.01  3.45%   
Vascular Biogenics' future price is the expected price of Vascular Biogenics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vascular Biogenics performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
  
Please specify Vascular Biogenics' target price for which you would like Vascular Biogenics odds to be computed.

Vascular Biogenics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vascular Biogenics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vascular Biogenics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Vascular Biogenics is not yet fully synchronised with the market data
Vascular Biogenics has some characteristics of a very speculative penny stock
Vascular Biogenics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 658 K. Net Loss for the year was (32.3 M) with profit before overhead, payroll, taxes, and interest of 554 K.
Vascular Biogenics currently holds about 34.15 M in cash with (31.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 13.0% of the company outstanding shares are owned by insiders

Vascular Biogenics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vascular Stock often depends not only on the future outlook of the current and potential Vascular Biogenics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vascular Biogenics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding77.6 M
Cash And Short Term Investments20.7 M

Vascular Biogenics Technical Analysis

Vascular Biogenics' future price can be derived by breaking down and analyzing its technical indicators over time. Vascular Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vascular Biogenics. In general, you should focus on analyzing Vascular Stock price patterns and their correlations with different microeconomic environments and drivers.

Vascular Biogenics Predictive Forecast Models

Vascular Biogenics' time-series forecasting models is one of many Vascular Biogenics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vascular Biogenics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Vascular Biogenics

Checking the ongoing alerts about Vascular Biogenics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vascular Biogenics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vascular Biogenics is not yet fully synchronised with the market data
Vascular Biogenics has some characteristics of a very speculative penny stock
Vascular Biogenics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 658 K. Net Loss for the year was (32.3 M) with profit before overhead, payroll, taxes, and interest of 554 K.
Vascular Biogenics currently holds about 34.15 M in cash with (31.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 13.0% of the company outstanding shares are owned by insiders
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Vascular Stock

If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities